Efficacy of high-versus moderate-dose statin therapy on lower extremity artery disease after revascularization

Creative Commons License

Kup A., Kanar B., Uslu A., Zehir R., Akaslan D., KEPEZ A.

MARMARA MEDICAL JOURNAL, vol.35, no.1, pp.36-41, 2022 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.5472/marumj.1056187
  • Journal Name: MARMARA MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.36-41
  • Keywords: Statin treatment, Percutaneous transluminal angioplasty, Peripheral artery disease, RISK-FACTORS, ATORVASTATIN, OUTCOMES, METAANALYSIS, SIMVASTATIN, ANGIOPLASTY
  • Marmara University Affiliated: Yes

Abstract

Aim: Statins are one of the most important agents in the treatment of atherosclerotic peripheral arterial disease. We aim to compare high - and moderate-dose stain therapy in patients with lower extremity artery disease (LEAD) who have undergone percutaneous transluminal angioplasty (PTA).